title: Spondyloarthritis: a window of opportunity?
authors.affiliation: Université Paris Est Créteil, Laboratoire d'Investigation Clinique (LIC) EA4393, 94010 Créteil, France; AP-HP, Hôpital Henri-Mondor, Service de Rhumatologie, 51, avenue Maréchal-de-Lattre-de-Tassigny, 94010 Créteil, France. Electronic address: pascal.claudepierre@hmn.aphp.fr.
authors.forename: Pascal
authors.initials: P
authors.lastname: Claudepierre
mesh_terms: D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D018450:Disease Progression; D042241:Early Diagnosis; D006801:Humans; D007249:Inflammation / Q000175:diagnosis / Q000188:drug therapy; D008279:Magnetic Resonance Imaging; D011379:Prognosis; D025241:Spondylarthritis / Q000175:diagnosis* / Q000188:drug therapy; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000893:Anti-Inflammatory Agents; D014409:Tumor Necrosis Factor-alpha
keywords: Ankylosing spondylarthritis; Early treatment; Spondyloarthritis; Window of opportunity